Session » Measures & Measurement of Healthcare Quality Poster

Date: Monday, November 9, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 1588

A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids

9:00AM-11:00AM: Abstract Number: 1591

A Quality Improvement Project to Increase Vitamin D Prescribing for Pediatric Patients on Glucocorticoids

9:00AM-11:00AM: Abstract Number: 1593

Adherence to Weight-Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Rheumatoid Arthritis and Systemic Lupus Erythematosus: Results of a Quality Improvement Initiative

9:00AM-11:00AM: Abstract Number: 1589

An Initiative to Improve Timely Glucocorticoid Tapering in Vasculitis

9:00AM-11:00AM: Abstract Number: 1612

Assessing Patient Self-Reported Transition Readiness in a Large Pediatric Rheumatology Center

9:00AM-11:00AM: Abstract Number: 1615

Assessing Preparation for Care Transition Among Adolescents with Rheumatologic Disease: A Quality Assessment with Patient Survey

9:00AM-11:00AM: Abstract Number: 1602

Assessing the Psychometric Properties of a Measure of Patient Empowerment with Patients with Arthritis

9:00AM-11:00AM: Abstract Number: 1582

Average Follow-up Time After Telemedicine Visit Is Longer Than Conventional Face-to-Face Visit in Outpatient Rheumatology Practice During COVID-19 Pandemic

9:00AM-11:00AM: Abstract Number: 1590

Bone Health in ANCA – Associated Vasculitis Patients

9:00AM-11:00AM: Abstract Number: 1621

Cervical Cancer Screening Among Women with Systemic Lupus Erythematosus or Prescribed Tumor Necrosis Alpha-inhibitors Who Receive Outpatient Rheumatology Care

9:00AM-11:00AM: Abstract Number: 1596

Coproduction of Care for Veterans with RA: Improving Elicitation and Documentation of Patient Goals

9:00AM-11:00AM: Abstract Number: 1610

Cutaneous Side Effects of Hydroxychloroquine in Rheumatic Diseases –Combination of “Traditional” Multivariate Analysis for Risk Factors AndClassification Model Development Using Supervised Machine Learning –Single Centre Retrospective Cohort Study in India

9:00AM-11:00AM: Abstract Number: 1622

Determining the Zoster Vaccination Rate Among Veterans on Chronic Immunosuppressive Therapy at the Southeast Louisiana Veterans Healthcare System – a Quality Indicator

9:00AM-11:00AM: Abstract Number: 1611

Documentation of Pregnancy Counseling in SSA-Positive Patients of Childbearing Potential: A Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 1607

Effectiveness of Dietary Counseling on Gout Management and Risk Factors for Metabolic Syndrome in Gout Patients

9:00AM-11:00AM: Abstract Number: 1598

Efficacy of Universal Depression Screening in a Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 1618

Frequency and Cost of Repeat HLA-B27 Testing Within the National Capital Consortium over a Calendar Year

9:00AM-11:00AM: Abstract Number: 1620

Hepatitis B Screening Practices When Prescribing Tocilizumab or Tofacitinib in Real World Practice

9:00AM-11:00AM: Abstract Number: 1594

Hydroxychloroquine Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution

9:00AM-11:00AM: Abstract Number: 1619

Immunoglobulin G Subclass Ordering Patterns for IgG4-Related Disease at an Academic Medical Center

9:00AM-11:00AM: Abstract Number: 1583

Impact of Telehealth Implementation on Practice Patterns and Electronic Health Record Utilization During COVID19

9:00AM-11:00AM: Abstract Number: 1587

Improving Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in an Internal Medicine Resident Clinic: A Quality Improvement Initiative

9:00AM-11:00AM: Abstract Number: 1592

Improving Documentation of Smoking Cessation Counseling Among Spondyloarthropathy Smokers

9:00AM-11:00AM: Abstract Number: 1624

Improving Pneumococcal Vaccination in Veterans with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1623

Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol

9:00AM-11:00AM: Abstract Number: 1613

Improving Transition Policy Dissemination and Care Team Communication in Pediatric Rheumatology Clinic Through Standardization of Workflow and Electronic Health Record Documentation

9:00AM-11:00AM: Abstract Number: 1605

Knowledge of Biosimilars and Perceptions of Biosimilar Naming Conventions in Clinical Practice

9:00AM-11:00AM: Abstract Number: 1585

Lessons Learned Through Rapid Quality Improvement for Telehealth Implementation in an Academic Rheumatology Practice During the COVID-19 Pandemic

9:00AM-11:00AM: Abstract Number: 1606

Mortality with Idiopathic Inflammatory Myositis in an Academic Hospital Setting: A Five-year Retrospective Study

9:00AM-11:00AM: Abstract Number: 1617

New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network

9:00AM-11:00AM: Abstract Number: 1603

P4 Index Correlates with RAPID3 and Disease-Specific Indices in Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA)

9:00AM-11:00AM: Abstract Number: 1601

Pilot Testing Supports Utility of a Point-of-Care Dashboard to Enhance Patient and Clinician Partnerships in the Management of RA

9:00AM-11:00AM: Abstract Number: 1625

Pneumocystis Jiroveci Pneumonia in Immunocompromised Patients with Rheumatologic Disease in a Single, Tertiary Medical Center

9:00AM-11:00AM: Abstract Number: 1600

Relationship Between Electronic Health Record Vendor and Performance on Patient-reported Outcome Quality Measures in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry

9:00AM-11:00AM: Abstract Number: 1586

Rheum Service: Comprehensive Virtual Care During COVID-19

9:00AM-11:00AM: Abstract Number: 1608

Survey of Minimally-Invasive Ultrasound-Guided Synovial Biopsy Performed at Rheumatology Centres

9:00AM-11:00AM: Abstract Number: 1616

Systematic Review of Effectiveness Outcomes Reported in Rheumatology Transition Literature

9:00AM-11:00AM: Abstract Number: 1584

Telemedicine Visits During COVID-19 Improved Clinic Show Rates

9:00AM-11:00AM: Abstract Number: 1609

The Accuracy of Administrative Health Data for Identifying Patients with Rheumatoid Arthritis: A Validation Study Using Medical Records in Western Australia

9:00AM-11:00AM: Abstract Number: 1604

The Impact of the COVID-19 Pandemic on Rheumatology Practice: A Study in 15 Arab Countries

9:00AM-11:00AM: Abstract Number: 1614

Use of a Best Practice Alert to Encourage Transition Planning and Readiness

9:00AM-11:00AM: Abstract Number: 1597

Use of a Clinical Dashboard Improves the Documentation of Disease Severity Scores and May Facilitate the Implementation of Treat to Target Therapy

9:00AM-11:00AM: Abstract Number: 1595

Using Rheumatoid Arthritis Communication Tool Developed by the RISE Learning Collaborative to Promote Shared Decision-Making

9:00AM-11:00AM: Abstract Number: 1599

Workflows for Collecting and Using Patient-reported Outcomes Across Rheumatology Practices

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].